Does DARATUMUMAB Cause Rash maculo-papular? 108 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 108 reports of Rash maculo-papular have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.4% of all adverse event reports for DARATUMUMAB.
108
Reports of Rash maculo-papular with DARATUMUMAB
0.4%
of all DARATUMUMAB reports
5
Deaths
69
Hospitalizations
How Dangerous Is Rash maculo-papular From DARATUMUMAB?
Of the 108 reports, 5 (4.6%) resulted in death, 69 (63.9%) required hospitalization, and 9 (8.3%) were considered life-threatening.
Is Rash maculo-papular Listed in the Official Label?
Yes, Rash maculo-papular is listed as a known adverse reaction in the official FDA drug label for DARATUMUMAB.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Rash maculo-papular?
SULFAMETHOXAZOLE\TRIMETHOPRIM (935)
AMOXICILLIN (871)
VANCOMYCIN (642)
PIPERACILLIN\TAZOBACTAM (629)
PANTOPRAZOLE (589)
LAMOTRIGINE (568)
ALLOPURINOL (550)
CARBOPLATIN (529)
ACETAMINOPHEN (499)
CLINDAMYCIN (484)
Which DARATUMUMAB Alternatives Have Lower Rash maculo-papular Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE